HER2-Positive Breast Cancer | Topics

Decision Making in Selecting Treatment in HER2+ BC
May 18, 2021

Experts provide insights on clinical decision-making in the setting of patient with HER2+ breast cancer.

The Role of Prophylactic Therapy in HER2+ BC
May 18, 2021

Key opinion leaders explore the appropriateness of prophylactic therapy for brain metastases and share their thoughts on best practices.

Management Approaches for Patients with HER2+ BC at Risk for Brain Metastases
May 11, 2021

An expert panel of breast oncologists discusses factors they consider when deciding whether to screen a patient with HER2+ breast cancer for brain metastases.